IPLL provides guidance and legal advice to pharmaceutical, biotechnology, and medical device companies on matters at the intersection of FDA regulation and intellectual property. Our attorneys have extensive experience in advising companies on market protection strategies, data exclusivity, patent term restoration, transactions, licensing, and due diligence. We also provide advice in these subsections: • Agrochemicals • Biodefense • Biologics and Biosimilars • Bioprocessing and Biofuels • Chemical • Life Science
Nanotechnology is the engineering of functional systems at the molecular scale, a technology based upon recognized scientific disciplines and material science fabrication techniques where individual molecules and even atoms can be arranged into precise structures. As a field and area for product development, nanotechnology includes numerous scientific disciplines, including microfabrication, molecular biology, organic chemistry, semiconductor physics and surface science. As the technology may be used to generate new materials and
Integration of smart technologies including engineering, biology, nanotechnology in medical device product development continues to accelerate and revolutionize medical treatments. In a fast growing industry, a comprehensive intellectual property strategy is critical for players in the medical device sector. IPLL’s qualified attorneys combine their scientific prowess and their legal expertise to advise medical devices companies on issues involving corporate governance and formation, mergers and acquisitions, public offerings, public and private
Intellectual property portfolio development and enforcement are key in today’s dynamic business environment fueled by rapid advancements in the electronics industry. IPLL helps clients to achieve the optimal use of IP for their business objectives by offering advice on management, creating enforcement-ready portfolios, negotiating licensing deals, performing IP due diligence for investment and acquisition opportunities and defending or enforcing clients’ intellectual property rights. We cover these areas of the electronics
IPLL’s Litigation and Appeals practice is a leader across the business and technology sectors. Our attorneys possessing a long track record of achievement in complex commercial disputes, where the stakes are exceedingly high. We also bring exceptional industry knowledge and provide leading edge advice. With experienced trial and appellate lawyers, we litigate and win commercial disputes across multiple industries and geographies. Our value proposition is a holistic approach combined with
Wireless Recognition Technologies LLC v. A9.com, Amazon.com, Inc., Google, Inc., Nokia, Inc. and Ricoh Innovations, Inc., No. 3:12-CV-01217 (N.D. Cal. Mar. 12, 2012), transferred from No. 2:10-CV-00364 (E.D. Tex. Sep. 14, 2010); Wireless Recognition Technologies LLC v. Nokia Corporation and Ricoh Company, Ltd., No. 5:12-CV-01218 (N.D. Cal. Mar. 12, 2012), transferred from No. 2:10-CV-00365 (E.D. Tex. Sep. 14, 2010); Wireless Recognition Technologies LLC v. A9.com, Amazon.com, Inc., Google, Inc., Nokia,
Network Gateway Solutions, LLC v. Adtran, Inc., Audiocodes Ltd., Audiocodes Inc., Avaya Inc., Cisco Systems Inc., Genband Inc., Juniper Networks,Inc., Alcatel-Lucent, Alcatel-Lucent USA Inc., Media5 Corporation, Mediatrix Telecom Inc., Metaswitch Inc., Mitel Networks Corporation, Mitel Networks Inc., Multi-Tech Systems Inc., Patton Electronics Co., Quintum Technologies LLC, Siemens AG, Siemens Corporation, Sonus Networks Inc. and Zhone Technologies Inc., No. 1:2009-CV-00667 (D. Del. Sep. 4, 2009). Representation of defendants Media5 Corporation and
Morningware, Inc. v. Hearthware Home Products, Inc., No. 1:2009-CV-04348 (N.D. Ill. July 20, 2009). Representation of defendant/counterclaimant in action involving infringement of patent directed to cookware technology, trade dress infringement, unfair competition and product disparagement under § 43(a) of the Lanham Act, deceptive trade practices under Illinois state law, common law unfair competition and commercial disparagement.